AI Bias Analysis
4 models · Takes ~15 seconds
Lilly has signed a deal with AI drug developer Insilico that’s worth $115 million up front and approximately $2.75 billion in biobucks
Source
Stat News
Opens original article in a new tab
(MedPage Today) -- NEW ORLEANS -- Microaxial flow pump circulatory support with the Impella device during percutaneous coronary intervention (PCI) didn't help outcomes for complex patients not in cardiogenic shock, two randomized trials at the...
(MedPage Today) -- NEW ORLEANS -- Women with pregnancy-associated spontaneous coronary artery dissection (P-SCAD) had a more severe presentation than those with SCAD who were not pregnant (NP-SCAD), according to a cohort study. Based on prospectively...
(MedPage Today) -- "Conceptually, you might think, 'Who would do something so stupid?'" -- Elliot Fishman, MD, of Johns Hopkins Medicine in Baltimore, discussing the malicious potential of deepfake X-rays. "Sadly, younger physicians are about...
(MedPage Today) -- NEW ORLEANS -- The more intensive LDL cholesterol target guidelines recommended for secondary prevention in high-risk patients with atherosclerotic cardiovascular (CV) disease improved outcomes in a randomized trial from South...